Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000160488 | SCV000211053 | uncertain significance | not provided | 2014-06-23 | criteria provided, single submitter | clinical testing | This variant is denoted FANCC c.1363G>C at the cDNA level, p.Ala455Pro (A455P) at the protein level, and results in the change of an Alanine to a Proline (GCA>CCA). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. FANCC Ala455Pro was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Since Alanine and Proline differ in some properties, this is considered a semi-conservative amino acid substitution. FANCC Ala455Pro occurs at a position that is poorly conserved across species and is not located in a known functional domain. In silico analyses predict that this variant is unlikely to alter protein structure or function. Based on currently available information, it is unclear whether FANCC Ala455Pro is pathogenic or benign. We consider it to be a variant of uncertain significance. |